2-MIN READ
Before Second Nationwide Dry Run of Vaccination, Covishield Shots Reach Delhi from Pune
Vials with a sticker reading, COVID-19 / Coronavirus vaccine / Injection only and a medical syringe are seen in front of an AstraZeneca logo. (REUTERS/Dado Ruvic/Illustration/File Photo)
Flight no AI-850 from Pune to Delhi will carry the first the consignment of the vaccines to the national capital, an official said.
FOLLOW US ON:
The first consignment of Covid-19 vaccine Covishield will land in Delhi at 9pm on Thursday. This comes a day ahead of second nationwide mock drill on the coronavirus vaccination scheduled to be held on January 8.
Synopsis
The vaccine, developed with the University of Oxford, is made from a virus which is a weakened version of a common cold virus (adenovirus), that has been genetically changed so that it is impossible for it to grow in humans.
PTI
New Delhi | Mumbai: The South African government has signed up a deal with Serum Institute of India to supply 1.5 million doses of Covid-19 vaccines to the country, even as Indian government remains silent on the purchase contract.
In the first tranche of the order Serum will supply one million doses in January and reminder doses in February, the statement from Zwelini Mkhize, minister of health, South Africa said.
Covishield, Covaxin to be available very soon in India: Health Minister Harsh Vardhan
Premium
1 min read
Share Via
Read Full Story
Ahead of the Covid-19 vaccine dry run on 8 January, Union Health Minister Harsh Vardhan met the health ministers of states and Union Territories at 12.30 on Thursday.
Guiding the state health ministers on conducting the dry run, Harsh Vardhan said, Feedback on the dry run of Covid vaccine in four states was reviewed. We have made improvements based on the feedback. Tomorrow dry run will be done in 33 states and Union Territories.
TRENDING STORIESSee All
2 min read
1 min read
Premium
Overall India has around 2,29 lakh active coronavirus cases (File)
New Delhi:
The Union Health Secretary wrote to the Maharashtra, Kerala, Chhattisgarh and Bengal governments on Thursday to underline the need for strict vigil and prompt action to arrest the recent spike in coronavirus cases in each of the states. These four states account for 59 per cent of all active Covid cases in the country, the Health Secretary, Rajesh Bhushan, said in his letter.
The state governments were also warned against allowing testing rates to drop - particularly in light of the spread of a mutated (and considerably more infectious) strain of the virus - and to aggressively implement the Test-Track-Treat strategy deployed by other states.
Patralekha Chatterjee | Why trust needs to be the key word in 2021
Published : Jan 7, 2021, 4:00 am IST
Updated : Jan 7, 2021, 4:00 am IST
Opacity in decision-making, attempts to gloss over mistakes or polarise the populace on any count will punch holes in the trust narrative
The controversy, however, is more about the drug regulator’s emergency approval to the second coronavirus vaccine, the indigenously produced Covaxin, before critical efficacy data of the third phase of clinical trials are out.
India has a good story to tell when it comes to vaccines it produces more than 60 per cent of all vaccines sold across the globe. Why then has India’s final approval of two Covid-19 vaccines kicked up such a storm, with many respected health experts and scientists calling it a hasty decision?